Search results
Results From The WOW.Com Content Network
In June 2024, the FDA advised manufacturers of licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 formula) should be monovalent JN.1 vaccines. [77] Based on the further evolution of SARS-CoV-2 and a rise in cases of COVID-19, the agency subsequently determined and advised manufacturers that the preferred JN.1 ...
This web page provides an overview of 40 COVID-19 vaccines that have been granted full or emergency use authorizations by various regulatory authorities. It also shows the usage status, eligibility, and suspension of each vaccine in different countries and regions.
Learn about the different types of COVID-19 vaccines, how they work, and how they were developed and distributed worldwide. Find out the latest data on vaccine doses administered, approval status, and Nobel Prize winners.
A COVID-19 vaccine card is a record showing information about the vaccine received, such as the date, brand, and location. Different countries issue digital or paper cards, and some require them for travel or other purposes.
PeduliLindungi, now SatuSehat, is a national integrated health data exchange platform and a COVID-19 contact tracing app in Indonesia. It was launched in 2020 and became mandatory for public transportation and some public places, but was later rebranded as a citizen health app in 2023.
The COVID-19 vaccination in Indonesia is an ongoing mass immunization in response to the COVID-19 pandemic in Indonesia. On 13 January 2021, the program commenced when President Joko Widodo was vaccinated at the presidential palace. [1] In terms of total doses given, Indonesia ranks third in Asia and fifth in the world. [2]
Learn about the mRNA vaccine developed by Moderna and its partners, authorized for use in various countries and regions. Find out its efficacy, safety, variants, and bivalent versions.
The Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield [31] and Vaxzevria [1] [32] among others, is a viral vector vaccine for the prevention of COVID-19. It was developed in the United Kingdom by Oxford University and British-Swedish company AstraZeneca , [ 33 ] [ 34 ] [ 35 ] using as a vector the modified ...